Effects of alcohol on human carboxylesterase drug metabolism

RB Parker, ZY Hu, B Meibohm, SC Laizure - Clinical pharmacokinetics, 2015 - Springer
Abstract Background and Objective Human carboxylesterase-1 (CES1) and human
carboxylesterase-2 (CES2) play an important role in metabolizing many medications …

Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition

ZY Hu, AN Edginton, SC Laizure, RB Parker - Clinical pharmacokinetics, 2014 - Springer
Abstract Background and Objective Human carboxylesterase-1 (CES1) is an enzyme that is
primarily expressed in the liver, where it plays an important role in the metabolism of many …

The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans

J Oh, SH Lee, H Lee, JY Cho, SH Yoon, IJ Jang… - PLoS …, 2017 - journals.plos.org
Background Human carboxylesterase 1 (CES1) is a serine esterase that hydrolyses various
exogenous and endogenous compounds including oseltamivir, a prodrug used to treat …

Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variants

HJ Zhu, JS Markowitz - Drug Metabolism and Disposition, 2009 - ASPET
Oseltamivir phosphate is an ethyl ester prodrug widely used in the treatment and prevention
of both Influenzavirus A and B infections. The conversion of oseltamivir to its active …

[HTML][HTML] Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation

HJ Zhu, JS Markowitz - European journal of clinical pharmacology, 2013 - Springer
Carboxylesterase 1 (CES1) is the major hepatic hydrolytic enzyme responsible for the
metabolism of many therapeutic agents, toxins, and endogenous compounds existing as …

Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humans

EK Tarkiainen, JT Backman… - Clinical …, 2012 - Wiley Online Library
Bioactivation of the antiviral agent oseltamivir to active oseltamivir carboxylate is catalyzed
by carboxylesterase 1 (CES1). After the screening of 860 healthy Finnish volunteers for the …

The impact of carboxylesterases in drug metabolism and pharmacokinetics

L Di - Current drug metabolism, 2019 - ingentaconnect.com
Background: Carboxylesterases (CES) play a critical role in catalyzing hydrolysis of esters,
amides, carbamates and thioesters, as well as bioconverting prodrugs and soft drugs. The …

[HTML][HTML] The effect of carboxylesterase 1 (CES1) polymorphisms on the pharmacokinetics of oseltamivir in humans

Y Suzaki, N Uemura, M Takada, T Ohyama… - European journal of …, 2013 - Springer
Purpose The aim of this study was to examine whether carboxylesterase 1 (CES1A) genetic
polymorphisms affect the pharmacokinetics of oseltamivir. Methods Thirty healthy Japanese …

In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors

R Thomsen, HB Rasmussen, K Linnet… - Drug Metabolism and …, 2014 - ASPET
Carboxylesterase 1 (CES1) is the major hydrolase in human liver. The enzyme is involved in
the metabolism of several important therapeutic agents, drugs of abuse, and endogenous …

Association of oseltamivir activation with gender and carboxylesterase 1 genetic polymorphisms

J Shi, X Wang, RF Eyler, Y Liang, L Liu… - Basic & clinical …, 2016 - Wiley Online Library
Oseltamivir, an inactive anti‐influenza virus prodrug, is activated (hydrolysed) in vivo by
carboxylesterase 1 (CES 1) to its active metabolite oseltamivir carboxylate. CES 1 functions …